A trial comparing chemotherapy with no further treatment after surgery to remove sarcoma of the womb
Cancer type:
Status:
Phase:
This trial was for women who have had surgery to remove their womb to treat a type of cancer called leiomyosarcoma. The trial compared chemotherapy after surgery with no further treatment. Cancer Research UK supported this trial.
More about this trial
If you have your womb removed (a 
) as treatment for leiomyosarcoma, you are closely followed up afterwards to check for signs of the cancer coming back.
Most women will remain cancer free, but sometimes the cancer does come back. If this happens, you may have chemotherapy. There are several chemotherapy drugs that doctors can use, including a combination of the 2 drugs gemcitabine and docetaxel (Taxotere), and another drug called doxorubicin.
In this trial, researchers wanted to see if having these chemotherapy drugs after surgery to remove leiomyosarcoma reduced the chance of the cancer coming back.
Summary of results
This trial closed early as the researchers were unable to get enough women to take part. Because of this the trial team are not able to produce any significant results.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Dr Helen Hatcher
Supported by
Cancer Research UK
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Other information
This is Cancer Research UK trial number CRUK/11/051.
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
